Cargando…
Comorbidity and health-related quality of life in people with a chronic medical condition in randomised clinical trials: An individual participant data meta-analysis
BACKGROUND: Health-related quality of life metrics evaluate treatments in ways that matter to patients, so are often included in randomised clinical trials (hereafter trials). Multimorbidity, where individuals have 2 or more conditions, is negatively associated with quality of life. However, whether...
Autores principales: | Butterly, Elaine W., Hanlon, Peter, Shah, Anoop S. V., Hannigan, Laurie J., McIntosh, Emma, Lewsey, Jim, Wild, Sarah H., Guthrie, Bruce, Mair, Frances S., Kent, David M., Dias, Sofia, Welton, Nicky J., McAllister, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844862/ https://www.ncbi.nlm.nih.gov/pubmed/36649256 http://dx.doi.org/10.1371/journal.pmed.1004154 |
Ejemplares similares
-
Treatment effect modification due to comorbidity: Individual participant data meta-analyses of 120 randomised controlled trials
por: Hanlon, Peter, et al.
Publicado: (2023) -
Assessing trial representativeness using serious adverse events: an observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data
por: Hanlon, Peter, et al.
Publicado: (2022) -
Representation of people with comorbidity and multimorbidity in clinical trials of novel drug therapies: an individual-level participant data analysis
por: Hanlon, Peter, et al.
Publicado: (2019) -
Correlations between comorbidities in trials and the community: An individual-level participant data meta-analysis
por: Crowther, Jamie, et al.
Publicado: (2023) -
Identifying frailty in trials: an analysis of individual participant data from trials of novel pharmacological interventions
por: Hanlon, Peter, et al.
Publicado: (2020)